Board Meetings for THYROCARE
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| THYROCARE | Thyrocare Technologies Limited | 13 Jun 2019 | Other business matters | To consider other business matters | |
| THYROCARE | Thyrocare Technologies Limited | 18 May 2019 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2019, dividend and other business matters | |
| THYROCARE | Thyrocare Technologies Limited | 09 Feb 2019 | Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2018 and interim dividend if any | |
| THYROCARE | Thyrocare Technologies Limited | 03 Nov 2018 | Financial Results | To consider and approve the financial results for the period ended September 30, 2018 | |
| THYROCARE | Thyrocare Technologies Limited | 11 Aug 2018 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 | |
| THYROCARE | Thyrocare Technologies Limited | 04 Aug 2018 | Buyback | To consider buyback for equity shares | |
| THYROCARE | Thyrocare Technologies Limited | 28 Apr 2018 | Financial Results/Dividend/Other business matters | To consider and approve the financial results (Stand-alone and Consolidated) for the period ended March 31, 2018, dividend and other business matters | |
| THYROCARE | Thyrocare Technologies Limited | 03 Feb 2018 | Results | inter alia, to consider and approve Unaudited Stand-alone as well as Consolidated Financial Results of the Company for the quarter / nine months ended December 31, 2017. | |
| THYROCARE | Thyrocare Technologies Limited | 03 Feb 2018 | Results/Dividend | The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on February 03, 2018 inter alia, to consider and approve Unaudited Stand-alone as well as Consolidated Financial Results of the Company for the quarter / nine months ended December 31, 2017. The Company has now informed the Exchange that the Board may consideration of declaring an interim dividend .(Purpose Revised) | |
| THYROCARE | Thyrocare Technologies Limited | 09 Dec 2017 | Results/Dividend | To, inter alia: (1) Consider and approve unaudited Standalone as well as Consolidated Financial Results of the Company for the quarter /half year ended September 30, 2017.(2) Consider declaration of Interim Dividend for the Financial Year 2017-18. | |
| THYROCARE | Thyrocare Technologies Limited | 12 Aug 2017 | Results | Inter alia, to consider and approve unaudited Stand-alone and Consolidated Financial Results of the Company for the quarter ended June 30, 2017. | |
| THYROCARE | Thyrocare Technologies Limited | 09 May 2017 | Results | Pursuant to Regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that a meeting of our Board of Directors of the Company will be held on Tuesday, the 9th May 2017, at the Corporate Office of the Company, inter alia, to consider and approve Stand-alone and Consolidated Audited Financial Results of the Company for the quarter / financial year ended March 31, 2017 and to consider granting of Employee Stock Options for the financial year ended March 31, 2017. Please also note that pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, the trading window of the Company will remain closed for trading in Company s equity shares for Directors / Designated Employees / Connected Persons from May 03, 2017 to May 12, 2017 (both days inclusive). | |
| THYROCARE | Thyrocare Technologies Limited | 28 Jan 2017 | Results/Dividend | to consider, inter alia, the Unaudited Stand-alone as well as Consolidated financial results of the Company for the quarter / nine months ended December 31, 2016. The Board will also consider payment of interim dividend, if any, after taking into consideration the capital expenditure and other cash requirements for the remaining period of the current financial year and the next financial year. | |
| THYROCARE | Thyrocare Technologies Limited | 24 Oct 2016 | Results | to inter alia, consider and approve unaudited Stand-alone and Consolidated financial results of the Company for the quarter / half year ended September 30, 2016. Also pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, the trading window of the Company will remain closed for trading in Company s equity shares for Directors / Designated Employees of the Company from October 17, 2016 to October 28, 2016 (both days inclusive). The trading window will reopen on Monday, October 31, 2016. | |
| THYROCARE | Thyrocare Technologies Limited | 22 Jul 2016 | Results | To, inter alia, consider and approve unaudited Stand-alone and Consolidated Financial Results for the Quarter ended June 30, 2016 |